Blood Virus Testing Market: By Test Type (Full Blood Count Test, Test for Inflammation, Immunology Test, Liver Function Test, Others), By Virus Type (Hepatitis viruses, Human Immunodeficiency Virus, Human T-Lymphotropic Virus, Others), By End User (Hospitals, Diagnostic Centers, Clinics, Ambulatory Surgical Centers, Others) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Blood Virus Testing Market was valued at USD 15,602.3 million in 2022 and is poised to grow at a CAGR of 6.4% from 2023 to 2029. Blood virus testing is a process of detecting viruses in blood samples. blood virus testing helps in identifying the virus-causing infection and to determine best treatment. Blood virus is useful in early detection of infections which can improve treatment outcomes. Increasing prevalence of blood borne viral infection such as hepatitis-B, C, HIV is expected to drive the blood virus testing market growth. The increasing incidence of viral infections are expected to increase the demand for accurate and reliable diagnostic tests to diagnose in early stages. In addition, increasing demand for blood and blood-derived products which are used for transfusion surgeries, and other medical procedures is expected to boost the growth of blood virus testing market as it is necessary to test for blood borne viral infections to prevent the transmission of viral infections.

Furthermore, the advancement in diagnostics and the development of new diagnostic tools and techniques such as nucleic acid testing and other diagnostic tests to improve the accuracy and timeliness of blood virus testing is expected to boost the growth of virus testing market at a significant rate over the forecast period. However, high cost associated with blood virus testing in developing countries along with limitation for current diagnostic technologies, especially in patients with low viral load and patients co-affected with multiple infection are expected to restraint the growth of blood virus testing market. Moreover, the growing focus on preventive healthcare and rising use of blood tests for early detection along with the technological advancement and innovation in diagnostics are anticipated to provide an opportunity to the market key players in the growth of blood virus testing market over the forecast period.


Blood Virus Testing Market Key Developments:
  • In April 2020, Abbott launched the third Covid 19 test, a laboratory-based antibody test.
  • In July 2020, researchers in prestigious Monash University in Melbourne have developed a new blood test to detect Covid 19 virus in 20 minutes.

Blood Virus Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.4%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Blood Virus Testing Market Dynamics

The blood virus testing market is expected to grow over the forecasted period due to the increasing prevalence of blood borne viral infections such as HIV, Hepatitis-C, B. these infections are transmitted through contaminated blood, body fluids, and tissues. Early diagnosis and treatment of viral infection are crucial to prevent transmission and disease progression. For instance, according to the World Health Organization, about 325 million people globally were living with hepatitis B and C in 2019. The rising burden of blood borne viral infection is expected to increase the demand for blood virus testing across the globe and drive the growth of blood virus testing market over the forecast period.

Blood Virus Testing Market Segmentation

By Virus Type
  • Hepatitis viruses
  • Human Immunodeficiency Virus
  • Human T-Lymphotropic Virus
  • Others
By Test Type
  • Full Blood Count Test
  • Test for Inflammation
  • Immunology Test
  • Liver Function Test
  • Others
By End User
  • Hospitals
  • Diagnostic Centers
  • Clinics
  • Ambulatory Surgical Centers
  • Others
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

High cost of blood testing is expected to hinder the growth of blood virus testing market over the forecast period.

The leading players in the global Blood Virus Testing market are BioMérieux, Bio-Rad Laboratories, Abbott, Randox Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Omega Diagnostics Group, OraSure Technologies.

The Blood Virus Testing market is segmented based on Virus Type, Test Type, End User, and geography.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1.Executive Summary
2.Global Blood Virus Testing Market Introduction 
2.1.Global Blood Virus Testing Market  - Taxonomy
2.2.Global Blood Virus Testing Market  - Definitions
2.2.1.Test Type
2.2.2.Virus Type
2.2.3.End User
2.2.4.Region
3.Global Blood Virus Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Blood Virus Testing Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Blood Virus Testing Market  By Test Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Hepatitis viruses
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Human Immunodeficiency Virus
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Human T-Lymphotropic Virus
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Blood Virus Testing Market  By Virus Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Full Blood Count Test
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Test for Inflammation
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Immunology Test
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Liver Function Test
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Blood Virus Testing Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diagnostic Centers
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Clinics
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Ambulatory Surgical Centers
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Global Blood Virus Testing Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Blood Virus Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Hepatitis viruses
9.1.2.Human Immunodeficiency Virus
9.1.3.Human T-Lymphotropic Virus
9.1.4.Others
9.2.  Virus Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Full Blood Count Test
9.2.2.Test for Inflammation
9.2.3.Immunology Test
9.2.4.Liver Function Test
9.2.5.Others
9.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Diagnostic Centers
9.3.3.Clinics
9.3.4.Ambulatory Surgical Centers
9.3.5.Others
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Blood Virus Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Hepatitis viruses
10.1.2.Human Immunodeficiency Virus
10.1.3.Human T-Lymphotropic Virus
10.1.4.Others
10.2.  Virus Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Full Blood Count Test
10.2.2.Test for Inflammation
10.2.3.Immunology Test
10.2.4.Liver Function Test
10.2.5.Others
10.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Diagnostic Centers
10.3.3.Clinics
10.3.4.Ambulatory Surgical Centers
10.3.5.Others
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Blood Virus Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Hepatitis viruses
11.1.2.Human Immunodeficiency Virus
11.1.3.Human T-Lymphotropic Virus
11.1.4.Others
11.2.  Virus Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Full Blood Count Test
11.2.2.Test for Inflammation
11.2.3.Immunology Test
11.2.4.Liver Function Test
11.2.5.Others
11.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Diagnostic Centers
11.3.3.Clinics
11.3.4.Ambulatory Surgical Centers
11.3.5.Others
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Blood Virus Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Hepatitis viruses
12.1.2.Human Immunodeficiency Virus
12.1.3.Human T-Lymphotropic Virus
12.1.4.Others
12.2.  Virus Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Full Blood Count Test
12.2.2.Test for Inflammation
12.2.3.Immunology Test
12.2.4.Liver Function Test
12.2.5.Others
12.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Diagnostic Centers
12.3.3.Clinics
12.3.4.Ambulatory Surgical Centers
12.3.5.Others
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Blood Virus Testing Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Hepatitis viruses
13.1.2.Human Immunodeficiency Virus
13.1.3.Human T-Lymphotropic Virus
13.1.4.Others
13.2.  Virus Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Full Blood Count Test
13.2.2.Test for Inflammation
13.2.3.Immunology Test
13.2.4.Liver Function Test
13.2.5.Others
13.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Diagnostic Centers
13.3.3.Clinics
13.3.4.Ambulatory Surgical Centers
13.3.5.Others
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.BioMérieux
14.2.2.Bio-Rad Laboratories
14.2.3.Abbott
14.2.4.Randox Laboratories
14.2.5.F. Hoffmann-La Roche
14.2.6.Thermo Fisher Scientific
14.2.7.Omega Diagnostics Group
14.2.8.OraSure Technologies
15. Research Methodology 
16. Appendix and Abbreviations 
  • BioMérieux
  • Bio-Rad Laboratories
  • Abbott
  • Randox Laboratories
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Omega Diagnostics Group
  • OraSure Technologies

Adjacent Markets